M4MM
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Highly Capitalized Network-HCN tracked meaningful steps in operational strengthening, capital readiness, and program performance across the Cannabis and Psychedelics sectors during the past two weeks. The capital markets finally spoke, and they ...
Trulieve Approved to Uplist to NYSE in Historic Milestone for U.S. Cannabis Industry
TALLAHASSEE, Fla. — June 5, 2026 — In a landmark moment for the U.S. Cannabis industry, Trulieve Cannabis Corp. announced today that it has received approval to list its subordinate voting shares on the New ...
Psilocybin Shows Promise in Treating Cocaine Addiction
BIRMINGHAM – For the first time, a peer-reviewed, randomized clinical trial showed that psilocybin significantly reduced cocaine use when combined with structured psychotherapy. The findings, published in JAMA Network Open by researchers at the University ...
Why the Endocannabinoid System Is the Future of Cannabis Medicine
NEW YORK- Cannabis medicine is entering a more serious phase. For years, the conversation has focused on pain, sleep, anxiety, appetite, and symptom relief. Those remain important, but they may only be the beginning. The ...
Cannabis, Inflammation, and the Next Frontier in Root-Cause Medicine
NEW YORK- Cannabis medicine is moving beyond pain, sleep, and anxiety. One of the most important next frontiers may be inflammation, because the endocannabinoid system plays a direct role in how the body regulates immune ...
Why Metabolic Dysfunction May Be the Next Frontier for Cannabinoid Medicine
NEW YORK- Metabolism is the system that determines how the body produces, distributes, and uses energy, and it sits at the center of modern chronic disease. While it is often reduced to a discussion of ...
Cresco Labs Reports Q1 2026 Financial Results
CHICAGO – Cresco Labs Inc. released its first-quarter results, showcasing the ongoing efforts of one of the largest MSOs to strengthen operations across its footprint while preparing for potential changes at the federal level. With ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Highly Capitalized Network-HCN tracked meaningful steps in operational strengthening, capital readiness, and program performance across the Cannabis and Psychedelics sectors during the past two weeks. The capital markets finally spoke, and they ...
Trulieve Approved to Uplist to NYSE in Historic Milestone for U.S. Cannabis Industry
TALLAHASSEE, Fla. — June 5, 2026 — In a landmark moment for the U.S. Cannabis industry, Trulieve Cannabis Corp. announced today that it has received approval to list its subordinate voting shares on the New ...
Psilocybin Shows Promise in Treating Cocaine Addiction
BIRMINGHAM – For the first time, a peer-reviewed, randomized clinical trial showed that psilocybin significantly reduced cocaine use when combined with structured psychotherapy. The findings, published in JAMA Network Open by researchers at the University ...
Red Light Holland Taps Scott Melker to Lead Bitcoin Strategy Following Banking Setback
LOS ANGELES- Red Light Holland Corp. an Ontario-based psychedelics company known for its psilocybin truffles, announced a strategic pivot on July 14, 2025: appointing crypto influencer Scott Melker—known as “The Wolf of All Streets”—as Senior Advisor and ...
HYTN Secures Health Canada Drug Licence to Propel Cannabinoid Prescription Drug Pathway
LOS ANGELES- Vancouver-based HYTN Innovations Inc. (CSE: HYTN; OTC Pink: HYTNF) announced on July 14, 2025, that it has been granted a Cannabis Drug Licence (CDL) by Health Canada, effective July 2. This licence enhances HYTN’s existing Drug Establishment Licence ...
AYR Wellness Secures Extension of Debt Waiver Ahead of Financial Deadline
LOS ANGELES- AYR Wellness Inc. a vertically integrated multi-state cannabis operator, announced on July 11, 2025, that it has secured an additional amendment to its Limited Waiver Agreement with holders of a majority of its senior ...
Americans Overwhelmingly Oppose Federal Cannabis Prohibition
LOS ANGELES- A recent survey by the Pew Research Center reveals that just 12 percent of U.S. adults support a federal prohibition on cannabis, with the remaining 88 percent favoring legalization in some form—either solely ...
Republican Lawmakers Move to Block Cannabis Rescheduling, Undermining Federal Reform Efforts
WASHINGTON, D.C.. Just as the Biden administration’s long-awaited cannabis rescheduling effort appeared to be gaining traction, Republicans in the House Appropriations Committee have moved to shut it down—using their control of a key budget bill ...
MariMed Expands Access to Betty’s Eddies Chews to Medical Market in Maine
LOS ANGELES- MariMed Inc. has entered into a licensing agreement with The Stoned Moose, LLC, to distribute its full-spectrum Betty’s Eddies fruit chews in both adult-use and medical cannabis channels across Maine. Previously restricted to ...
Senate Panel Flags Misleading Cannabis Marketing, Backs Psychedelics Research
LOS ANGELES- The Senate Appropriations Committee released a report accompanying the 2026 agriculture and FDA spending bill that raises concerns over deceptive marketing in the cannabis sector while endorsing expanded federal support for psychedelics research. ...
McConnell Seeks to Close 2018 Hemp “Loophole” in Senate Funding Bill
LOS ANGELES- Senate Republican leader Mitch McConnell is advancing a provision in the FY 2026 agriculture appropriations bill aimed at revising the federal hemp definition to bar products containing any “quantifiable” amount of THC. The action ...
Psilocybin Study Suggests Potential for Longevity Benefits
LOS ANGELES- New preclinical research indicates that psilocybin the active psychoactive compound in psychedelic mushrooms—may significantly extend lifespan in both human cells and aged mice. Published July 8, 2025, in npj Aging, the study found ...
Challenges Emerge Over Kentucky’s Medical Cannabis License Lottery
LOS ANGELES- A coalition of Kentucky-based businesses has filed legal proceedings challenging the fairness and constitutionality of the state’s April 2024 medical cannabis license lottery. The lawsuit, lodged in Jefferson Circuit Court on June 27, ...
Aegis Capital Maintains Buy Rating on atai Life Sciences with $8 Target
LOS ANGELES- Aegis Capital has reaffirmed its Buy rating on atai Life Sciences N.V. (NASDAQ: ATAI), maintaining a price target of $8 following the release of positive Phase 2b results for BPL-003, the company’s investigational ...
ICE Raids California Cannabis Farms as Budget Swells and Allegations Mount
CARPINTERIA, Calif. — In a sweeping operation that has stirred legal, political, and cultural tensions across California, federal immigration authorities executed high-profile raids on two cannabis farms operated by Glass House Brands, one of the ...
Legal Status of Cannabis in Europe
LOS ANGELES- A growing number of European countries now permit the use, cultivation or sale of cannabis under regulated conditions, driven by evolving public policy and emerging economic opportunity. Germany legalized limited recreational use on ...
New Lawsuit Challenges Lottery Process for Kentucky Medical Cannabis Licenses
LOS ANGELES- A group of Kentucky-based applicants has filed a lawsuit arguing that the state’s lottery system for awarding medical cannabis licenses is unconstitutional and unfairly structured. The suit, filed on June 27 in Jefferson ...
Organigram Expands U.S. Market Through Collective Project Direct to Consumer Launch and THC Beverage Portfolio Expansion
LOS ANGELES- Organigram Global Inc. Canada’s largest cannabis producer by market share, has entered a significant new phase in its U.S. strategy. Through its recently acquired subsidiary, Collective Project, the company has launched a direct-to-consumer ...
